Company intelligence / Profile preview

TFBS Bioscience

Xizhi District, New Taipei City, Taiwantfbsbio.com ↗

Ownership: Private
Employees: ~70
Development stage: Commercial

Overview

TFBS Bioscience is Taiwan’s first specialist viral vector CRO/CDMO, offering end-to-end GMP-compliant viral vector manufacturing and biosafety testing for gene and cell therapies. The company supports preclinical through clinical development with comprehensive laboratory services[1][2][4].

Modalities: Viral vectorBiologicGene therapyCell therapy (as manufacturing/testing support)
Industry: Contract Research Organization

Beyond the preview

Go deeper on TFBS Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TFBS Bioscience.

Explore the full profile